Skip to main content

Save up to 30% on Elsevier print and eBooks with free shipping. No promo code needed.

Save up to 30% on print and eBooks.

Cell Press Reviews: Cancer Therapeutics

  • 1st Edition - December 10, 2013
  • Editor: Cell Press
  • Language: English
  • Paperback ISBN:
    9 7 8 - 0 - 1 2 - 4 2 0 1 9 2 - 7
  • eBook ISBN:
    9 7 8 - 0 - 1 2 - 7 9 9 9 1 7 - 3

Cell Press Reviews: Cancer Therapeutics informs, inspires, and connects cancer researchers at all stages in their careers with timely, comprehensive reviews written by leaders i… Read more

Cell Press Reviews: Cancer Therapeutics

Purchase options

LIMITED OFFER

Save 50% on book bundles

Immediately download your ebook while waiting for your print delivery. No promo code is needed.

Institutional subscription on ScienceDirect

Request a sales quote

Cell Press Reviews: Cancer Therapeutics informs, inspires, and connects cancer researchers at all stages in their careers with timely, comprehensive reviews written by leaders in the field and curated by Cell Press editors. The publicatio offers a broad view of some of the most compelling topics in cancer therapeutics including:

Genetic approaches for personal oncology

Targeting epigenetic dysregulation and protein interaction networks

Vaccines and antibodies in cancer immunotherapy

Tumor heterogeneity and chemotherapy resistance

Tumor associated macrophages in anticancer treatment

Contributions come from leading voices in the field, including:
- Daniel A. Haber, Director of Massachusetts General Hospital Cancer Center and Professor at Harvard Medical School
- Tony Kouzarides, Professor at the University of Cambridge, Deputy Director of the Wellcome Trust/Cancer Research UK Gurdon Institute, and a founder of the cancer drug discovery company Chroma Therapeutics
- Charles L. Sawyers, Chair of the Human Oncology and Pathogenesis Program at Memorial Sloan Kettering Cancer Center, President of the American Association for Cancer Research, member of the presidentially appointed National Cancer Advisory Board, and recipient of the 2013 Breakthrough Prize in Life Sciences

Cell Press Reviews: Cancer Therapeutics is part of the Cell Press Reviews series, which features reviews published in Cell Press primary research and Trends reviews journals.